David Schenkein will step down from Agios Phar­ma­ceu­ti­cals ’ board of di­rec­tors at the end of the month “to de­vote more ...
Moderna is working on restoring investors' faith that its Covid-19 vaccine was not a one-hit-wonder. It also has to show it ...
A series of actions by President Donald Trump's administration have provoked profound anxiety among academic labs that ...
Bristol Myers Squibb's Opdualag (relatlimab/Opdivo) fails Phase 3 melanoma trial, adding to mixed results for LAG-3/PD-1 targeting immunotherapies.
Agios' Pyrukynd met primary endpoint in Phase 3 study for children with PK deficiency who don't need regular transfusions, ...
Knownwell expands with 6 new Chicago locations, adding to existing Boston and Dallas clinics. CEO reports 78% virtual visits.
The Senate on Thursday confirmed Robert F. Kennedy Jr. as secretary of Health and Human Services, putting a longtime ...
Idorsia’s plan to hand over the global rights to its blood pressure drug Tryvio has ended in disappointment after a deal announced in November fell through.